Enforcement radar
Real enforcement — not just rule changes
FDA & FTC enforcement hitting GLP-1 and compounded products — recalls, warning letters, and FTC actions, each labeled by type. If the pharmacy or outsourcing facility your med spa sources from lands here, that’s a patient-safety and liability problem today — not a rule that might change. Monitoring, not legal advice.
Monitored daily · sources last scanned Sep 28, 2026newest action Sep 16, 2026
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get a specific “what to do” wherever a change calls for one — in one daily email, for your states. See one unlocked → · Pricing →
- CRITICALDEVICE RECALLSep 16, 2026
FDA device recall (Class II): Product Name: DermaV Laser System Model/Catalog Number: DermaV Medical laser device that delivers pulsed laser energy a…
FDA recalls DermaV Laser System; check for safety compliance.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - CAUTIONWARNING LETTERFDA: VAIAug 25, 2026
FDA Warning Letter: Advance-Esthetic LLC (Devices)
FDA says Zemits CrystalFrax Pro, Abigon Pro and Bionexis Lite Pro RF and light body-contouring devices lack required FDA approval or clearance.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERAug 24, 2026
FDA Warning Letter: Peak Performance Peptides (Drugs)
FDA says Peak Performance Peptides' "research use only" semaglutide, retatrutide and other peptides, and the BAC water sold with them, are unapproved.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERAug 24, 2026
FDA Warning Letter: Peptide Partners, LLC (Drugs)
FDA says Peptide Partners' "research use only" GLP-1s and other injectable peptides are unapproved drugs. Health claims on its own product pages were FDA's evidence that they were intended for human use.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERAug 24, 2026
FDA Warning Letter: Royal Peptides LLC (Drugs)
FDA says Royal Peptides' "research use only" GLP-1s and other peptides are unapproved drugs. Its weight-loss claims, and the bacteriostatic water, "peptide guide" and "peptide calculator" sold alongside them, were FDA's evidence they were meant for injection in people.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 380…
FDA recalls semaglutide from Apollo Care due to contamination.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 380…
FDA recalls semaglutide 12.5mg due to contamination risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 3801 …
Recall of contaminated semaglutide vials.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injectio…
FDA recalls semaglutide 7.5mg due to particulate contamination.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl…
Recall of compounded semaglutide due to contamination reported.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, …
Recall of semaglutide from Apollo Care due to contamination risk.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injecti…
Apollo Care recalls semaglutide for harmful particulate matter.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection On…
FDA recalls semaglutide due to contamination risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection On…
Important recall: Check your inventory for affected semaglutide vials.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, 380…
FDA recalls semaglutide vials due to contamination concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 19, 2026
FDA recall (Class II): Semaglutide 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, …
FDA recalls semaglutide due to contamination risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALWARNING LETTERFDA: OAIJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
Water Spa De Soleil uses to make over-the-counter topical products failed testing 51 times from 2024 to 2025. FDA had cited similar problems in 2021.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA says buyketaminepowderonline.com (formerly ketaminelab.org) sells unapproved, misbranded ketamine powder online.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 17, 2026
FDA Warning Letter: Herbal Dermals Ltd (Drugs)
FDA issued a Warning Letter to Herbal Dermals Ltd.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 17, 2026
FDA Warning Letter: Wholesale Peptide (Drugs)
FDA says Wholesale Peptide's injectable "Prostamax" and gonadorelin are unapproved new drugs.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 17, 2026
FDA Warning Letter: Herbal Dermals Ltd (Drugs)
FDA Warning Letter issued to Herbal Dermals Ltd.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 17, 2026
FDA Warning Letter: Herbal Dermals Ltd (Drugs)
Herbal Dermals Ltd received an FDA Warning Letter; verify details.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 17, 2026
FDA Warning Letter: Herbal Dermals LLC Fz (Drugs)
FDA says Gotucream, sold online as a balanitis treatment cream, is an unapproved new drug.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFTC ACTIONJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
What to do — members only.Become a member →FTC Enforcementprimary source ↗ - CRITICALFDA ACTIONMay 27, 2026
FDA recall (Class II): Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, Fl 34108, …
FDA recalls contaminated Liraglutide Injection.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALWARNING LETTERFDA: OAIMay 12, 2026
FDA Warning Letter: Fresenius Kabi Compounding, LLC (Drugs)
FDA Warning Letter issued to Fresenius Kabi Compounding, LLC.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - MONITORFDA ACTIONApr 22, 2026
FDA recall (Class II): Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Bea…
FDA recalls semaglutide compound over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALWARNING LETTERFDA: OAIApr 22, 2026
FDA Warning Letter: Active Cosmetics Manufacturing Inc (Drugs)
FDA cites Active Cosmetics Manufacturing for releasing OTC topical drugs after failed microbial tests, including S. aureus.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERFDA: OAIApr 20, 2026
FDA Warning Letter: Foshan Miwei Cosmetics Co., Ltd. (Drugs)
FDA cites Foshan Miwei Cosmetics for releasing OTC drug products without testing active-ingredient strength or microbes.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERApr 2, 2026
FDA Warning Letter: Purolea Cosmetics Lab (Drugs)
FDA cites Purolea Cosmetics Lab for insects and filth in its plant and for untested homeopathic drug products.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERApr 1, 2026
FDA Warning Letter: Pure Indulgence Aesthetics (Drugs)
FDA says a Texas med spa administered far more Botox than it bought from AbbVie, and so had sourced toxin from unauthorized suppliers.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERMar 31, 2026
FDA Warning Letter: Mile High Compounds (Drugs)
FDA says the "research-only" semaglutide, tirzepatide and retatrutide sold by Mile High Compounds are unapproved injectable drugs. The firm's own weight-loss dosing guides, shared through its online forum, were FDA's evidence that the products were meant for people.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERMar 31, 2026
FDA Warning Letter: Gram Peptides (Drugs)
FDA says GRAM Peptides' "research use only" retatrutide and tirzepatide, sold with bacteriostatic water, are unapproved drugs.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONDEVICE RECALLMar 18, 2026
FDA device recall (Class II): Clarity II Laser System; Model No. 1110200210.
FDA recalls Clarity II Laser System for safety concerns.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - CRITICALFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
FDA recalls Semaglutide for sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, NDC …
FDA recalls Tirzepatide injection over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…
FDA recalls specific compounded GLP-1 products due to quality issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls compounded GLP-1 product over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFDA ACTIONMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls Tirzepatide Inj over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…
Important recall on compounded Semaglutide products affecting med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORDEVICE RECALLJan 28, 2026
FDA device recall (Class II): Brand Name: Leaseir Product Name: Leaseir Mhr Xcell Model/Catalog Number: Mhr 110-b Software Version: 1.5.0.0 Product D…
Leaseir MHR Xcell laser recalled for safety issues.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - MONITORFDA ACTIONJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je…
FDA recalls Semaglutide injection over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
FDA recalls GLP-1 product; take immediate action.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
FDA recalls GLP-1 injection over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
Urgent: FDA recalls compounded semaglutide injection.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
Urgent FDA recall of Tirzepatide Injection impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONOct 15, 2025
FDA recall (Class II): Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 20…
Important FDA recall on GLP-1 compounded product.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONOct 15, 2025
FDA recall (Class II): Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca Raton…
FDA recalls GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONOct 15, 2025
FDA recall (Class II): Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca R…
FDA recalls semaglutide over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Class II recall of Boothwyn Pharmacy semaglutide injection (subpotent).
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Urgent: GLP-1 injection recall for med spas sourcing compounded products.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important recall of GLP-1 compounded product.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
FDA recalls compounded GLP-1 product due to processing controls issue.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important FDA recall for compounded GLP-1 product impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…
FDA recalls compounded GLP-1 product over safety issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls a GLP-1 product; check your supply immediately.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Ongoing recall of compounded GLP-1 product.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) s…
Stay informed: GLP-1 injectable recall may affect your practice.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile…
FDA recalls compounded GLP-1 product.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
Important recall for GLP-1 products; take immediate action.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Alert: GLP-1 product recall due to processing issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls compounded GLP-1 product due to safety concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Important recall for compounded GLP-1 products impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide for sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide injections; action needed.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Su…
FDA recalls compounded GLP-1 product for sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, S…
Class II recall of Thrive Health tirzepatide/B12 over sterility.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80112
FDA recalls compounded GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 …
FDA recalls GLP-1 product due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
Class II recall of Thrive Health tirzepatide over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONJul 2, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80…
FDA recalls GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONMay 7, 2025
FDA recall (Class II): Wegovy (Semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
Urgent recall of Wegovy due to temperature abuse risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗
Want this watched for your states + the full radar? Claim founding access →